✦ LIBER ✦

Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

✍ Scribed by Karam, Jose A.; Devine, Catherine E.; Urbauer, Diana L.; Lozano, Marisa; Maity, Tapati; Ahrar, Kamran; Tamboli, Pheroze; Tannir, Nizar M.; Wood, Christopher G.

Book ID: 121509738
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 952 KB
Volume: 66
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2014.01.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP57-13 PHASE II TRIAL OF NEOADJUVANT AX

MP57-13 PHASE II TRIAL OF NEOADJUVANT AXITINIB IN PATIENTS WITH LOCALLY ADVANCED NON-METASTATIC CLEAR CELL RENAL CELL CARCINOMA

✍ Karam, Jose; Devine, Catherine; Urbauer, Diana; Lozano, Marisa; Maity, Tapati; A 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 40 KB

A Phase 2 Trial of Sunitinib in Patients

A Phase 2 Trial of Sunitinib in Patients with Advanced Non–clear Cell Renal Cell Carcinoma

✍ Nizar M. Tannir; Elizabeth Plimack; Chaan Ng; Pheroze Tamboli; Nebiyou B. Bekele 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Re: A Phase 2 Trial of Sunitinib in Pati

Re: A Phase 2 Trial of Sunitinib in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma

✍ Taneja, Samir S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 103 KB

Phase II trial of topotecan in patients

Phase II trial of topotecan in patients with advanced renal cell carcinoma

✍ Teresa Murray Law; David H. Ilson; Robert J. Motzer 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 159 KB

Phase II trial of trimetrexate in patien

Phase II trial of trimetrexate in patients with advanced renal cell carcinoma

✍ Sternberg, Cora N.; Yagoda, Alan; Scher, Howard; Bosl, George; Dershaw, David; R 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 160 KB

Phase II trial of Didemnin B in patients

Phase II trial of Didemnin B in patients with advanced renal cell carcinoma

✍ Robert Motzer; Howard Scher; Dean Bajorin; Cora Sternberg; George J. Bosl 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 115 KB

Twenty-three patients with advanced renal cell cancer were treated with Didemnin B. One partial response was achieved (5070) in 21 evaluable patients. An allergic reaction was noted in four patients including one patient with anaphylaxis. Didemnin B is not recommended in the treatment of renal cell